Go Pro
→ “This is the Perfect Tech Stock” (From Brownstone Research) (Ad)tc pixel Free BRBI Stock Alerts

BR Biopharma (BRBI) Dividend Yield, Date & History

BR Biopharma logo
$11.15 -0.05 (-0.44%)
As of 02:26 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

BR Biopharma Dividend Summary

Dividend Yield
3.68%
Annual Dividend
$0.41
Recent
Dividend Payment
Sep. 4
Dividend Payout Ratio
512.50%

BR Biopharma (BRBI) pays dividends, with an annual dividend of $0.41 per share and a dividend yield of 3.68%. Investors who owned the stock before the ex-dividend date of Monday, August 17, 2026 received the most recent payment of $0.1415 per share, paid on Friday, September 4, 2026. The company currently pays out 512.50% of its earnings and 14.60% of its cash flow as dividends.

Get Dividend Stock Ideas Daily

Enter your email address below to receive the DividendStocks.com newsletter, a daily email that contains dividend stock ideas, ex-dividend stocks, and the latest dividend investing news.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Dividend History

BRBI Dividend Payments by Quarter

The chart below displays up to four years of BR Biopharma's dividend payment history by quarter. The blue bars represent historical dividend payments, while the gray bars indicate future payments.

BRBI Dividend Yield Over Time

The chart below tracks BR Biopharma's dividend yield over the past four years. The line represents changes in yield by quarter, providing a clear view of trends over time.

BR Biopharma vs. The Competition

Compare BR Biopharma's annual dividend and yield with averages for Finance and NASDAQ companies to evaluate its performance against the market.

TypeBR BiopharmaFinance CompaniesNASDAQ Companies
Annual Dividend$0.41$0.07$1.57
Dividend Yield3.68%5.95%11.71%

BR Biopharma Dividend Payout Ratio

Dividend payout ratios express the dividend as a percentage of another metric, such as earnings or cash flow, and can be used to assess dividend sustainability.

TypePayout Ratio
Based on Trailing 12 Months of Earnings512.50%
Based on Cashflow14.60%

BR Biopharma Dividend History by Quarter

Export
AnnouncedPeriodPaymentPayment ChangeYieldEx-Dividend DateRecord DatePayable Date
8/7/2026quarterly$0.1415-$0.0055
3.75%		6.2%8/17/20268/17/20269/4/2026
5/8/2026quarterly$0.1470 - 4.58%5/19/20265/19/20266/5/2026

This table shows BR Biopharma's dividend history, including payout amounts, yield, dividend changes, and key dates. Use the date filter to explore data as far back as 2013 to analyze trends over time.

BR Biopharma Dividend - Frequently Asked Questions

The current dividend yield for BR Biopharma is 3.68%. Learn more on BRBI's dividend yield history.

The annual dividend for BRBI shares is $0.41. Learn more on BRBI's annual dividend history.

BR Biopharma pays quarterly dividends to shareholders.

BR Biopharma's most recent quarterly dividend payment of $0.1415 per share was made to shareholders on Friday, September 4, 2026.

BR Biopharma's most recent ex-dividend date was Monday, August 17, 2026.

The most recent change in the company's dividend was a decrease of $0.0055 on Friday, August 7, 2026.

The dividend payout ratio for BRBI is:
  • 512.50% based on the trailing year of earnings
  • 14.60% based on cash flow

BR Biopharma's dividend yield of 3.73% is lower than the average Finance company that issues a dividend. BR Biopharma's dividend payout ratio of 512.50% may not be sustainable.

Looking at the stock as a whole, market analysts rate BR Biopharma stock as a Sell, forecasting declining performance or overvaluation, indicating potential reasons to exit positions.

Related Companies
Dividend Tools
Stock Lists

MarketBeat compiles BR Biopharma dividend data from multiple sources, with the most recent dividend announced on 8/7/2026.
From Our Partners
Why major institutions are piling into this digital asset now
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely | Sponsoredtc pixel
“This is the Perfect Tech Stock”
Jeff Brown, the tech investor who identified Nvidia in 2016 before its 37,000% run, has flagged a new AI compa...
Brownstone Research | Sponsoredtc pixel
A “bloodbath” Is Coming
Reports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the co...
TradeSmith | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
Musk says UBI is coming. I say it's already here.
Elon Musk says AI could make money irrelevant by 2036. One income program already exists today, funded not by ...
Freedom Financial | Sponsoredtc pixel
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...
Porter & Company | Sponsoredtc pixel
The retirement income that answers “yes” when everything else says no
Todd Phillips has spent 30 years studying safe-money income. He says most so-called income sources fail one te...
Eagle Publishing | Sponsoredtc pixel
NNVC on Alert: FDA Validation and Outperform Rating!
NanoViricides (NYSE: NNVC) just landed FDA Rare Pediatric Disease Designation for NV-387 in Measles, adding to...
Equiscreen | Sponsoredtc pixel